Publication:
Hallucination Development with Montelukast in a Child with Asthma: Case Presentation

dc.authorscopusid55937683100
dc.authorscopusid55937699800
dc.authorscopusid55937522100
dc.authorscopusid55938305900
dc.authorscopusid24280435800
dc.authorscopusid7003707808
dc.contributor.authorKocyigit, A.
dc.contributor.authorÖksüz, B.G.
dc.contributor.authorYarar, F.
dc.contributor.authorUzun, F.
dc.contributor.authorİğde, M.
dc.contributor.authorİşlek, I.
dc.date.accessioned2020-06-21T14:04:17Z
dc.date.available2020-06-21T14:04:17Z
dc.date.issued2013
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kocyigit] Aysen, Samsun Education and Research Hospital, Samsun, Samsun, Turkey; [Öksüz] Banu Gülcan, Samsun Education and Research Hospital, Samsun, Samsun, Turkey; [Yarar] Fulya, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Uzun] Funda, Samsun Maternity and Child Health Hospital, Samsun, Turkey; [İĞde] Mahir, Samsun Education and Research Hospital, Samsun, Samsun, Turkey; [İşlek] İsmail, Umraniye Education and Research Hospital, Istanbul, Istanbul, Turkeyen_US
dc.description.abstractLeukotriene receptor antagonists(montelukast) have been used for many years in the treatment of asthma both acute and chronic stages. They are accepted commonly as safe but mostly possible side effects are ignored. However, montelukast also could lead to important adverse reactions like hallucinations. In literature only 2 reports have been found about hallucinations with it. One is a study which reports 3 patients from 48 children and the other is a 29 year-old case report. In our case, psychiatric adverse reactions of montelukast,especially hallucinations are reported similarly. We are presenting a child who had visual hallucinations after starting to use montekulast and after stopping the medicine these complaints disappeared in 48 hours. Although it is a safe drug, it should not be forgotten that it has psychiatric side effects which may be missed easily especially in children. Copyright© Winter 2013, Iran J Allergy Asthma Immunol. All rights reserved.en_US
dc.identifier.endpage399en_US
dc.identifier.issn1735-1502
dc.identifier.issn1735-5249
dc.identifier.issue4en_US
dc.identifier.pmid23996717
dc.identifier.scopus2-s2.0-84888242938
dc.identifier.scopusqualityQ3
dc.identifier.startpage397en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/15592
dc.identifier.volume12en_US
dc.identifier.wosWOS:000323717200013
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherTehran University Medical Sciencesen_US
dc.relation.ispartofIranian Journal of Allergy, Asthma and Immunologyen_US
dc.relation.journalIranian Journal of Allergy Asthma and Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdverse Reactionsen_US
dc.subjectAsthmaen_US
dc.subjectChildrenen_US
dc.subjectHallucinationen_US
dc.subjectMontelukasten_US
dc.titleHallucination Development with Montelukast in a Child with Asthma: Case Presentationen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files